School of Medicine


Showing 1-10 of 12 Results

  • Paul A. Khavari, MD, PhD

    Paul A. Khavari, MD, PhD

    Carl J. Herzog Professor in Dermatology in the School of Medicine

    Current Research and Scholarly InterestsWe work in epithelial tissue as a model system to study stem cell biology, cancer and new molecular therapeutics. Epithelia cover external and internal body surfaces and undergo constant self-renewal while responding to diverse environmental stimuli. Epithelial homeostasis precisely balances stem cell-sustained proliferation and differentiation-associated cell death, a balance which is lost in many human diseases, including cancer, 90% of which arise in epithelial tissues.

  • Youn H Kim, MD

    Youn H Kim, MD

    The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research and Professor, by courtesy, of Medicine (Oncology) at the Stanford University Medical Center

    Current Research and Scholarly InterestsClinical research in cutaneous lymphomas, especially, mycosis fungoides; studies of prognostic factors, long-term survival results, and effects of therapies. Collaborative research with Departments of Pathology and Oncology in basic mechanisms of cutaneous lymphomas. Clinical trials of new investigative therapies for various dermatologic conditions or clinical trials of known therapies for new indications.

  • Phuong Khuu, MD

    Phuong Khuu, MD

    Clinical Assistant Professor, Dermatology

    BioPhuong Khuu, M.D., is a Clinical Assistant Professor in Pediatric Dermatology at Lucile Packard Children’s Hospital. Her clinical interests include children with complex dermatologic diseases and epidermolysis bullosa. Her research interest is in clinical management of epidermolysis bullosa.

  • Justin M Ko, MD, MBA, FAAD

    Justin M Ko, MD, MBA, FAAD

    Clinical Associate Professor, Dermatology

    BioDr. Ko joined Stanford Medicine in 2012 and serves as Medical Director and Chief of Medical Dermatology for Stanford Health Care. He is active in a number of leadership roles within the organization, and is intimately involved in various strategic and operational initiatives at SHC.

    Dr. Ko spearheads efforts around community outreach, screening and digital health. His passion for early cancer detection improving care delivery drives his efforts and collaborations to leverage advances in machine learning and artifical intellegence to increase the breadth of populations that can be reached. Some of this work is featured in Nature; more details can be found here: http://cs.stanford.edu/people/esteva/nature/. Further, he developed and runs a virtual teledermatology care delivery program at SHC; providing virtual visits for established patients and remote consultations for providers within the Stanford network. He welcomes opportunities to discuss and collaborate in these areas of investigation.

    Dr. Ko has also been driven to find new treatments for alopecia areata, an immune-mediated condition that can progress to total hair loss. He and his team recently completed a seminal study that has help to spur further trials investigating the potential of novel agents in treating alopecia areata: https://insight.jci.org/articles/view/89776 For more information on ongoing clinical trials, please email: alopeciatrials@stanford.edu. Dr. Ko sits on the clinical research advisory board of the National Alopecia Areata Foundation.

    He graduated magna cum laude from Harvard University and worked in investment banking; mergers and acquisitions at JP Morgan before going on to earn a combined medical and business degree at Tufts University. During medical school, he was a member of the Alpha Omega Alpha honor society. Dr. Ko then performed his residency at the Harvard Combined Dermatology Residency Training Program where he served as chief resident in his final year. He is board certified in dermatology by the American Board of Dermatology.

  • Bernice Kwong, MD

    Bernice Kwong, MD

    Clinical Associate Professor, Dermatology

    BioBernice Kwong, M.D., is Clinical Associate Professor of Dermatology and Director of the Inpatient Dermatology Consult Service. She has a special interest in the management of cutaneous complications that arise in cancer patients and currently runs the Supportive Dermato-Oncology Program at the Stanford Cancer Center, where she manages skin side effects of cancer therapies including chemotherapy related skin reactions, radiation dermatitis, and graft-versus-host disease. Dr. Kwong completed medical school at Yale University, and completed her dermatology residency at Stanford University in 2012.